|
|
Volumn 102, Issue 19 SUPPL., 2000, Pages 2434-2440
|
|
Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs
|
|
Author keywords
Atherosclerosis; Heart failure; Hypertension; Nitric oxide; Restenosis; Transplantation
|
|
Indexed keywords
2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID;
3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID;
4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID;
ATRASENTAN;
BOSENTAN;
BQ 610;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
CYCLO(DEXTRO TRYPTOPHYL DEXTRO CYSTEIC ACID PROLYL DEXTRO VALYLLEUCYL);
DARUSENTAN;
ENDOTHELIN;
ENDOTHELIN RECEPTOR ANTAGONIST;
N (HEXAHYDRO 1 AZEPINYLCARBONYL)LEUCYL(1 METHYL DEXTRO TRYPTOPHYL) DEXTRO TYROSINE;
N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN;
N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN;
PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN;
ARTICLE;
CARDIOVASCULAR DISEASE;
CELL PROLIFERATION;
CELL SURVIVAL;
EMBRYO DEVELOPMENT;
ENDOTHELIUM CELL;
HUMAN;
LUNG ENDOTHELIUM;
PRIORITY JOURNAL;
RECEPTOR BLOCKING;
TRANSCRIPTION REGULATION;
VASCULAR ENDOTHELIUM;
|
|
EID: 0034619523
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.102.19.2434 Document Type: Article |
|
Times cited : (523)
|
|
References (0)
|
